Announced
Synopsis
Ampersand Capital Partners-backed N2 Biomedical, a provider of nano-engineered surface treatment and coating services, agreed to merge with Precision Coating, a medical coatings service provider. Financial terms were not disclosed. "We are very excited to add N2's technologies and people to Precision Coating. N2 extends our coating platform technologies in ways that enhance our value proposition for customers. This is particularly true in orthopedics, where we can now offer engineered coating solutions across both instruments and implants," Bill Ellerkamp, Precision Coating President.
Show Details & Financials
Sort
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.